神经元特异性烯醇化酶、胶质纤维酸性蛋白和S100B作为开放性及血管内复杂主动脉手术脊髓缺血生物标志物的评估:单中心经验
该单中心回顾性研究纳入33例接受开放或血管内胸腹主动脉瘤修复术的患者,评估NSE、GFAP和S100B与运动诱发电位(MEP)振幅下降>50%(提示脊髓缺血)的相关性。结果显示所有生物标志物随时间升高,NSE和S100B不同测量时间点差异有统计学意义,但未发现与MEP显著下降或院内死亡相关。
要点
- NSE和S100B在开放及血管内胸腹主动脉瘤术后直接升高,但未显示与术中MEP显著下降相关。
- GFAP、NSE和S100B均未显示与院内死亡相关。
- 术后生物标志物升高不能单独作为脊髓缺血的早期指标。
核心结论
- NSE和S100B在开放和血管内胸腹主动脉瘤术后直接相关升高,但未观察到这些生物标志物水平与术中可测量的脊髓缺血指标明确相关。
研究设计与样本
- 回顾性评估2017年1月至2018年1月期间接受开放和血管内胸腹主动脉瘤修复术的33例患者(48.48%为男性)。
主要发现
- 院内死亡率为18.18%(n=6),其中5例因症状性胸腹主动脉瘤接受治疗。
- MEP下降见于18例(54.5%),其中16例(48.4%)在干预期间恢复。
- 脊髓缺血发生率为9.09%(n=3),包括2例血管内修复导致截瘫和1例开放修复导致轻截瘫。
- 所有生物标志物随时间升高,开放与血管内修复之间无统计学显著差异。
- NSE和S100B在不同测量时间点的差异有统计学意义(P < 0.0001,P = 0.0017)。
关键数值与推荐
- MEP振幅下降超过50%提示脊髓缺血。
- 单变量逻辑回归分析未观察到任何评估的生物标志物与终点「MEP显著下降」或「院内死亡」相关。
临床怎么用
- NSE和S100B术后升高可能反映手术相关损伤,但不足以单独作为脊髓缺血的早期检测工具。
局限性
- 单中心回顾性设计,样本量较小(33例)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Despite all efforts, spinal cord ischemia (SCI) is a relevant and feared complication after open and endovascular thoracoabdominal aortic aneurysm (TAAA) repair. Besides the established correlation of motor evoked potentials (MEPs) and SCI, the usage of biomarkers for early detection of SCI intraoperatively and postoperatively after TAAA surgery is scarcely described in literature. METHODS: The methods include retrospective assessment of 33 patients (48.48% male) undergoing open and endovascular TAAA repair between January 2017 and January 2018. Levels of the biomarkers neurone-specific enolase (NSE), glial fibrillary acidic protein (GFAP), and S100 B were correlated with a decrease of the amplitude of the MEPs of more than 50%, indicating SCI. Linear mixed models were applied to test for differences in the biomarker levels between open and endovascular surgery and between different times of measurement. Post hoc analyses were performed using Tukey's multiple comparisons test. Logistic regression models were used to investigate the association between GFAP, NSE, and S100 B levels at different times and a significant decrease in MEP or in-hospital mortality. RESULTS: Altogether, 19 patients were treated by endovascular repair; 14 patients were treated by open repair; 5 patients were treated because of a type I TAAA; 7 received treatment because of a type II TAAA; 7, 10, and 4 patients received type III, IV, or V TAAA repair, respectively. In-hospital mortality was 18.18% (n = 6); 5 of these patients were treated because of symptomatic TAAA. MEP decrease could be observed in 18 cases (54.5%), with 16 (48.4%) recovering during the intervention. SCI could be observed in 9.09% (n = 3), 2 endovascular repairs leading to paraplegia and one open repair leading to paraparesis. All biomarkers showed increasing levels over time, with no statistically significant difference between open and endovascular repair. The difference in NSE and S100 B levels between the different times of measurements was statistically significant (P < 0.0001, P = 0.0017, respectively). In a univariable logistic regression analysis, no correlation with the end points "significant decrease in MEP" or "in-hospital mortality" was observed for any of the assessed biomarkers. CONCLUSIONS: SCI-related biomarkers, namely NSE and S100 B, show a relevant increase directly after open and endovascular TAAA surgery, while no clear association between these biomarker levels and an intraoperatively measurable indicator for SCI could be observed.
引用
- Gombert A, Rückbeil MV, Kotelis D, et al. Assessment of Neurone-Specific Enolase, Glial Fibrillary Acidic Protein and S100 B as Spinal Cord Ischemia Biomarkers in Patients Undergoing Open and Endovascular Complex Aortic Surgery: A Single-Center Experience. Ann Vasc Surg. 2020. PMID: 31923599. doi:10.1016/j.avsg.2020.01.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。